Cite
HARVARD Citation
Yucebay, F. et al. (2019). Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience. Leukemia & lymphoma. 60 (9), pp. 2223-2229. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yucebay, F. et al. (2019). Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience. Leukemia & lymphoma. 60 (9), pp. 2223-2229. [Online].